Overview

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

Status:
Completed
Trial end date:
2020-01-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to characterize the dose-response relationship with respect to efficacy of Padsevonil administered concomitantly with up to 3 anti-epileptic drugs (AEDs) for treatment of observable focal-onset seizures in subjects with drug-resistant epilepsy.
Phase:
Phase 2
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.